Finance Gilead Sciences, Inc. (GILD) and Kite to Present Breakthrough Cancer Therapy Data at 2025 ASCO and EHAMay 19, 20250 Gilead Sciences, Inc. (NASDAQ:GILD) plans to current over 20 analysis abstracts—spanning each Gilead and its cell remedy unit Kite—at two…
